Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis


Creative Commons License

Ponti G., Maccaferri M., Manfredini M., Micali S., Torricelli F., Milandri R., ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.497, ss.76-80, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 497
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.cca.2019.07.011
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.76-80
  • Anahtar Kelimeler: Seminal cell-free DNA, cfDNA fragment size distribution, Non-invasive prostate cancer diagnosis, Benign prostatic hyperplasia, CIRCULATING DNA, QUANTIFICATION, TUMOR
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Liquid biopsy consists in the quantification and qualification of circulating cell-free DNA (cfDNA) and tumor-derived DNA (ctDNA) for cancer recognition. Recently, the characterization of seminal cfDNA (scfDNA) has been reported as a possible biomarker for prostate cancer (PCa) diagnosis.